Related Experiment Video
Updated: Apr 16, 2026

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Review of Treatment Options for Facial Synkinesis: Working Toward a Standardized Algorithm
Aileen Z Cui1, Shivam Patel2, Dana Smithnosky3
1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Background:
Facial synkinesis describes a sequela of transient facial nerve injury that can occur following viral reactivation syndromes such as Bell's palsy or following traumatic facial nerve injury. Facial synkinesis is frequently characterized by muscle hypertonicity, involuntary co-contraction of facial muscles, and spasm and can have severe functional and esthetic consequences. Although this condition is not curable, several treatment options exist; however, there is currently a lack of consensus regarding the appropriate timeline and sequence of synkinesis treatment strategies.
Summary:
Treatment for facial synkinesis is nuanced and constantly evolving. A range of both noninvasive and invasive treatment options exist, including physical therapy, chemodenervation with botulinum toxin, and various surgical interventions such as selective facial myectomy and selective facial neurectomy. The optimal treatment strategy is often dependent on patient preference, clinical presentation, and provider comfort and can be further complicated by confusion regarding the appropriate timeline for escalation of care. This review summarizes the current treatment trends and proposes a nuanced algorithm that integrates current practice and individualized decision-making to provide a flexible framework to care for this patient population.
Key Messages:
Management of facial synkinesis is complicated by the wide range of treatment options in addition to the lack of clear consensus on how to integrate these modalities into a cohesive treatment plan. The algorithmic approach outlined here represents one of several possible frameworks for evaluating and managing patients with this challenging condition.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Angle Closure Glaucoma: Treatment

